Selected Publications

Huang J, Sati S, Murphy C, Spencer CA, Rapp E, Prouty SM, Korte S, Ahart O, Sheng E, Jones P, Kersh AE, Leung D, Leung TH.: Granulocyte colony stimulating factor promotes scarless tissue regeneration. Cell Rep 43(10): 114742, Oct 2024.

Kersh AE, Sati S, Huang J, Murphy C, Ahart O, Leung TH.: CXCL9, CXCL10, and CCL19 synergistically recruit T lymphocytes to skin in lichen planus. JCI Insight 9(20): e179899, Oct 2024.

Sati S, Huang J, Kersh AE, Jones P, Ahart O, Murphy C, Prouty SM, Hedberg ML, Jain V, Gregory SG, Leung DH, Seykora JT, Rosenbach M, Leung TH.: Recruitment of CXCR4+ type 1 innate lymphoid cells distinguishes sarcoidosis from other skin granulomatous diseases. J Clin Invest 134(17): e178711, Sep 2024.

Abbott JJ, Jiang AJ, Rauck C, Frank DM, Fortuna D, Kersh A, Rubin AI.: Cutaneous metastatic gastric carcinoma with plasmacytoid features: A novel histopathologic pitfall in the diagnosis of primary cutaneous plasmacytoma. J Cutan Pathol 50(1): 8-11, Jan 2023.

Bhattacharya S, Basu S, Sheng E, Murphy C, Wei J, Kersh AE, Nelson CA, Bryer JS, Ashchyan HA, Steele K, Forrestel A, Seykora JT, Micheletti RG, James WD, Rosenbach M, Leung TH.: Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome. J Clin Invest 133: e162137, Jan 2023.

Bhattarcharya, S., Sheng, E., Murphy, C., Wei, J., Kersh, A.E., Nelson, C.A., Aschanyan, H.A., Steele, K., Forrestel, A., Seykora, J.T., Micheletti, R.G., James, W.D., Rosenbach, M., Leung, T.H. : Targeted therapy guided by molecular identification of PIK3R1 mutation in acute febrile neutrophilic dermatosis. J Clin Invest 133(1): e162137, 2023.

Torre EA, Kersh AE, Fischer AS, Xu X, Rosenbach M, Shields BE.: Angiokeratoma-like purpuric palmar nodules following chemotherapy. Dermatol Online J 27(8), Aug 2021.

Kersh AE, Johansen M, Ojeaga A, de la Feld S.: Hand Dermatitis in the Time of COVID-19: A Review of Occupational Irritant Contact Dermatitis. Dermatitis 32(2): 86-93, Mar-Apr 2021.

Kersh AE, Schuchter LM, Elenitsas R, Chu EY.: Hypohidrosis as an immune-related adverse event of checkpoint inhibitor therapy. Immunotherapy 12(13): 951-956, Sep 2020.

Kersh AE, Feldman RJ.: Autoimmune Sequelae Following Rituximab Therapy: A Review of the Literature and Potential Immunologic Mechanisms. J Clin Rheumatol 24(8): 427-435, Dec 2018.